Allergan Launches New R&D Facility

Sep 14th, 2012

Allergy has announced the opening of a new 93,000-square-foot research and development center in Bridgewater New Jersey. The state’s Lt. Governor Kim Guadagno, United States Senator Robert Menendez (D-NJ) and state Congressman Leonard Lance joined Allergan president and CEO David E. I. Pyott on September 4, 2012 to mark the grand opening. “I’m proud to join in celebrating this step forward for New Jersey’s thriving biotech and healthcare community with the expansion of Allergan’s operations to this new R&D facility, and especially proud to celebrate the hundreds of new, high-skill jobs it’s bringing to New Jersey,” said Senator Menendez. “This new facility is an investment in America’s Future, and investment in New Jersey’s economy and an investment in our nation’s intellectual infrastructure.”

More in News
Chr Retinal Duo Stacked
Murad Launches Serum Refills to Reduce Packaging by 85%
The brand is committed to expanding its refillable options in 2024 and beyond, including plans to make all serums refillable in the near future.
Apr 16th, 2024
The line utilizes fragments produced through vertical farming and already offers biomimetic collagen fragments Col-4-frag remastered (INCI: Not Provided) and Col-frag remastered (INCI: Not Provided).
LipoTrue to Expand Technology Portfolio with AI Obtained Ingredient for Acne Care at in-cosmetics Global
The line utilizes fragments produced through vertical farming and already offers biomimetic collagen fragments Col-4-frag remastered (INCI: Not Provided) and Col-frag remastered (INCI: Not Provided).
Apr 12th, 2024
Enhancing Confidence: Reverse by Aerolase for Scar Revision in Breast Augmentation & Reduction
Sponsored
Enhancing Confidence: Reverse by Aerolase for Scar Revision in Breast Augmentation & Reduction
The Reverse by Aerolase protocol harnesses the power of two state-of-the-art lasers, the Neo Elite and the Era Elite, to significantly enhance the appearance of scar tissue, redness, texture, and underlying pigment.
Feb 19th, 2024
papulopustular rosacea, close-up of the patient's cheek
Finding Safe Skin Care Options for Rosacea Patients
During Rosacea Awareness Month, the NRS and AARS are providing information to dermatologists and the general public about identifying rosacea symptoms and finding products that will not worsen the condition.
Apr 10th, 2024
91% of readers want the latest information on dermatologist recommended OTC skin care brands! Here are five exciting developments in derm-recommended OTC skin care.
5 Notable Developments in Derm-Recommended OTC Skin Care [Survey Results]
91% of readers want the latest information on dermatologist recommended OTC skin care brands! Here are five notable developments in derm-recommended OTC skin care.
Apr 8th, 2024
“At NAOS, we focus on skin health rather than surface aesthetics,' said Mikael Coste, chief digital officer at NAOS. 'Our unique ecobiological approach treats the skin as a dynamic ecosystem, addressing the root causes of imbalances and promoting skin function.'
NAOS x Haut.AI Launch AI-driven Skin Observer Tool for Personalized Beauty
The system taps Haut.AI's algorithms, which draw on more than 150 data points to generate comprehensive, clinical-grade skin analyses.
Apr 5th, 2024
red hair woman's hand applying cream on her shoulder. Concept of smooth skin, skincare, cosmetics, wellness center, healthy lifestyle
FDA Issues Warning on Certain OTC Analgesic Topical Products
The FDA has asked six companies to respond to the warning letters within 15 days of receipt stating how they will address these issues or provide their reasoning and supporting information as to why they think the products are not in violation of the law.
Apr 1st, 2024
Are you interested in learning about emerging professional neurocosmetic skin care? Answer our 1-question survey and let us know!
5 Emerging Trends in Professional Neurocosmetic Skin Care [Survey Results]
98% of readers are interested in learning about emerging professional neurocosmetic skin care! Here are five emerging trends in professional neurocosmetic skin care.
Apr 1st, 2024
CycloRetin's heterophyllin B molecule is a cyclic peptide that enhances skin matrix production, per Clariant, thereby improving collagen and reducing the signs of aging.
Clariant’s CycloRetin Taps Cyclic Peptides for a Retinol and Bakuchiol Alternative
CycloRetin's heterophyllin B molecule is a cyclic peptide that enhances skin matrix production, per Clariant, thereby improving collagen and reducing the signs of aging.
Mar 29th, 2024
Young adult asian woman makeup and face skin care using mobile phone for streaming content creator at home.
Dermatology App Recommendations Lack Supporting Evidence
According to a JAMA study, AI-driven apps also lacked transparency in algorithm development, data usage and user privacy.
Mar 28th, 2024
Face Reality Acne Med 10
Face Reality Skincare Launches Advanced Acne Med with Proprietary Micro-Smooth Technology
This advanced acne-fighting formula, available in three different strengths to support all clients’ needs.
Mar 27th, 2024
As Ozempic continues to take over the weight loss industry, its use is potentially expanding into gyms with the announcement of Life Time Fitness’ weight loss injections program.
The Ozempic Craze is Hitting the Gym Industry
As Ozempic continues to take over the weight loss industry, its use is potentially expanding into gyms with the announcement of Life Time Fitness’ weight loss injections program.
Mar 27th, 2024